Trial Profile

A double-blind, placebo and active controlled, single and multiple rising dose, safety, tolerance, and pharmacokinetic study of TR-701 [DA-70218] in normal healthy adults

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 13 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tedizolid (Primary) ; Linezolid
Indications Gram-positive infections; Nosocomial pneumonia; Pneumonia; Skin and soft tissue infections; Ventilator associated pneumonia
Focus Adverse reactions
Acronyms SAD/MAD
Sponsors Trius Therapeutics

Most Recent Events

15 Nov 2016 Results of this and one other phase 1 study assessing ophthalmologic and neurologic clinical examinations published in the American Journal of Therapeutics
17 Jun 2016 Results of a retrospective analysis (n=40) published in the Journal of Antimicrobial Chemotherapy
07 Aug 2013 Results published in Pharmacotherapy.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com